Erlotinib in Symptomatic Brain Metastases From a Lung Adenocarcinoma With a Sensitizing EGFR Mutation

被引：2
|
作者：
de Lima Araujo, Luiz H. [1 ,2 ]
da Silveira, Juliana S. [3 ]
Baldotto, Clarissa S. [1 ,2 ]
Zukin, Mauro [1 ,2 ]
Ferreira, Carlos G. [1 ,2 ]
机构：
[1] COI, NOT, Rio De Janeiro, Brazil
[2] Inst COI ICOI, Rio De Janeiro, Brazil
[3] Inst Nacl Canc INCA, Coordenacao Pesquisa Clin, Rio De Janeiro, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
TYROSINE KINASE INHIBITORS; CANCER;
D O I：
10.1097/JTO.0b013e31824cc34a
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1059 / 1060
页数：2
相关论文
共 50 条
  • [1] Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
    Porta, R.
    Sanchez-Torres, J. M.
    Paz-Ares, L.
    Massuti, B.
    Reguart, N.
    Mayo, C.
    Lianes, P.
    Queralt, C.
    Guillem, V.
    Salinas, P.
    Catot, S.
    Isla, D.
    Pradas, A.
    Gurpide, A.
    de Castro, J.
    Polo, E.
    Puig, T.
    Taron, M.
    Colomer, R.
    Rosell, R.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (03) : 624 - 631
  • [2] EGFR Amplification and Sensitizing Mutations Correlates with Survival from Erlotinib in Lung Adenocarcinoma Patients
    Ruiz-Patino, A.
    Castro, C.
    Ricaurte, L.
    Cardona, A.
    Rojas, L.
    Zatarain-Barron, Z.
    Wills, B.
    Reguart, N.
    Carranza, H.
    Vargas, C.
    Otero, J.
    Corrales, L.
    Martin, C.
    Archila, P.
    Rodriguez, J.
    Avila, J.
    Bravo, M.
    Pino, L.
    Rosell, R.
    Arrieta, O.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S161 - S162
  • [3] Diffuse Metastases of Lung Adenocarcinoma with EGFR mutation
    Kunimasa, Kei
    Masuda, Gen
    Watanabe, Naoki
    Ishida, Tadashi
    INTERNAL MEDICINE, 2012, 51 (06) : 685 - 686
  • [4] Mutational signatures in EGFR sensitizing mutation positive lung adenocarcinoma
    Kim, Eun Young
    Kim, Arum
    Chang, Yoon Soo
    CANCER RESEARCH, 2018, 78 (13)
  • [5] Erlotinib Versus Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Lung Adenocarcinoma
    Gerber, Naamit K.
    Yamada, Yoshiya
    Rimner, Andreas
    Shi, Weiji
    Riely, Gregory J.
    Beal, Kathryn
    Yu, Helena A.
    Chan, Timothy A.
    Zhang, Zhigang
    Wu, Abraham J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (02): : 322 - 329
  • [6] ERLOTINIB VERSUS RADIATION THERAPY FOR BRAIN METASTASES IN PATIENTS WITH EGFR-MUTANT LUNG ADENOCARCINOMA
    Gerber, Naamit K.
    Yamada, Yoshiya
    Shi, Weiji
    Zhang, Zhigang
    Riely, Gregory
    Beal, Kathryn
    Yu, Helena A.
    Chan, Timothy A.
    Rimner, Andreas
    Wu, Abraham J.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S902 - S902
  • [7] Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival
    Stanic, Karmen
    Zwitter, Matjaz
    Hitij, Nina Turnsek
    Kern, Izidor
    Sadikov, Aleksander
    Cufer, Tanja
    RADIOLOGY AND ONCOLOGY, 2014, 48 (02) : 173 - 183
  • [8] Erlotinib with pemetrexed/cisplatin for patients with EGFR wild-type lung adenocarcinoma with brain metastases
    Zhang, Yalei
    Yang, Haihong
    Yang, Xinyun
    Deng, Qiuhua
    Zhao, Meilin
    Xu, Xin
    He, Jianxing
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (03) : 449 - 453
  • [9] Brain Metastases in pulmonary Adenocarcinoma with EGFR-Mutation How Important is the Therapy with Erlotinib in Comparision to Radiotherapy?
    Seidel, Clemens
    Kortmann, Rolf-Dieter
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (02) : 205 - 207
  • [10] EGFR Amplification and Sensitizing Mutations Correlates with Survival from Erlotinib in Lung Adenocarcinoma Patients (MutP-CLICAP)
    Cardona, Andres
    Arrieta, Oscar
    Corrales, Luis
    Rojas, Leonardo
    Cuello, Mauricio
    Martin, Claudio
    Carranza, Hernan
    Vargas, Carlos
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S523 - S523
12345